A Scoping Review of Eosinophilic Pneumonia and Antidepressants: An Association Not to Be Overlooked [PDF]
Background: Eosinophilic pneumonias denote a rare condition, wherein infiltrating eosinophilic granulocytes accumulate within the lung parenchyma. Although eosinophilic pneumonias may be idiopathic, they are also associated with secondary causes.
Paschalis Steiropoulos +1 more
exaly +4 more sources
Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications [PDF]
Chronic eosinophilic pneumonia is a rare inflammatory lung disease that typically responds to systemic glucocorticoids but is frequently complicated by relapses and treatment-related toxicity.
Daniele Previtero +12 more
doaj +2 more sources
Rapid Onset of Mesalazine‐Induced Eosinophilic Pneumonia Manifesting 7 Days After Initiation: A Case Report [PDF]
Mesalazine is a recognised cause of drug‐induced eosinophilic pneumonia. The condition usually occurs after 2–6 months of therapy, and onset within the first week is rare.
Toshiaki Inazaki +12 more
doaj +2 more sources
Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management
Eosinophilic pneumonia (EP) is a rare disorder, comprising several heterogeneous diseases. Two major types of EP are acute eosinophilic pneumonia (AEP) and chronic eosinophilic pneumonia (CEP), both of which are characterized by marked accumulation of ...
Takafumi Suda, Yuzo Suzuki
exaly +3 more sources
A case report of phenytoin-induced eosinophilic pneumonia
Eosinophilic pneumonia comprises a rare and potentially serious group of lung diseases characterized by abnormal accumulation of eosinophils in the lungs. Many medications including the anticonvulsant phenytoin, have been implicated in the development of
Rhoda Annoh Gordon, Leann Silhan
exaly +3 more sources
Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma [PDF]
Sequential use of biologic therapies such as tezepelumab and mepolizumab may represent a steroid-sparing and effective treatment approach for managing distinct eosinophilic disorders, including eosinophilic pneumonia and eosinophilic otitis media, which ...
Osamu Matsuno, MD, PhD +5 more
doaj +2 more sources
Chronic Eosinophilic Pneumonia: A Diagnostic Challenge With Atypical Bronchoalveolar Lavage Findings and an Organizing Pneumonia Pattern [PDF]
Chronic eosinophilic pneumonia (CEP) is a rare eosinophilic lung disease. We report a 61‐year‐old man with asthma who presented with progressive exertional dyspnoea for 2 months and worsening productive cough for 2 weeks.
Yang‐Tai Lin +5 more
doaj +2 more sources
Pomalidomide-induced acute eosinophilic pneumonia: a case report [PDF]
Eosinophilic pneumonia secondary to drug exposure is a recognized but infrequent complication associated with a variety of medications, including oncological therapies.
Mathieu Megevet +5 more
doaj +2 more sources
Acute eosinophilic pneumonia with detection of pure Tropheryma whipplei in bronchoalveolar lavage fluid: a case report [PDF]
Acute eosinophilic pneumonia (AEP) is a rare but potentially severe respiratory illness. Tropheryma whipplei can also cause acute pulmonary infection, leading to atypical symptoms and computerized tomography (CT) findings.
Yi Hu, Jie Zhang, Ting Wang, Bing Xue
doaj +2 more sources
Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia [PDF]
Patients with chronic eosinophilic pneumonia often experience recurring disease and prolonged corticosteroid use with adverse effects. Benralizumab enabled corticosteroid discontinuation and successfully treated chronic eosinophilic pneumonia in our ...
Yoshiro Kai, MD, PhD, Yuichi Hishida, RT
doaj +2 more sources

